No Data
TD Cowen Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $225
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
AbbVie Is Maintained at Buy by TD Cowen
AbbVie Analyst Ratings
AbbVie Insiders Sell US$56m Of Stock, Possibly Signalling Caution
Express News | Abbvie : TD Cowen Raises Target Price to $225 From $195
loading...
Paul 1968 : The labor market is not strong, it's election time and they want everything to look good so that they can keep the one's in power right where they are at.
lsk529 :
Laine Ford : I will not cut.
Alice Lim choo : good
Alice Lim choo : good
View more comments...